siponimod hemifumarate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
MAYZENT siponimod 0.25 mg film coated tablet blister pack
AUST R: 310498
Active ingredients:
siponimod hemifumarate

Dosage form:
Tablet, film coated

Sponsor:
Novartis Pharmaceuticals Australia Pty Ltd

Phone:
1800 635 202

Deletion from market:
01 May 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative strengths are available. The sponsor is replacing this product with an alternative product - MAYZENT siponimod 1 mg film coated tablet blister pack (AUST R 395451)